Vural E, Suen J Y, Hanna E
Department of Otolaryngology, University of Arkansas for Medical Sciences, 4301 W. Markham, Slot 543, Little Rock, AR 72205, USA.
Head Neck. 1999 Dec;21(8):703-6. doi: 10.1002/(sici)1097-0347(199912)21:8<703::aid-hed4>3.0.co;2-h.
The purpose of this article is to define the outcome of intracranial extension of inverted papilloma and outline a rationale for management of this rare clinical presentation.
A review of patients with intracranial extension of inverted papilloma reported in the literature (18 patients), or treated in our institution (3 patients ) was performed. The data of these 21 patients were consolidated with regard to clinical presentation, treatment, and outcome. Nine patients, including 1 of our cases, had coexisting squamous cell carcinoma and therefore were excluded from the analysis. Twelve patients with "pure" inverted papilloma formed the basis of this study.
The majority of patients (83%) with intracranial inverted papilloma had recurrent disease. Patients with extradural disease had a survival rate of 86% with an average follow-up of 4.4 years. Eighty-six percent of these survivors were treated with craniofacial resection. In contrast, 75% of patients with intradural inverted papilloma were dead of disease with an average follow-up of 9.3 months regardless of the treatment modality.
Intracranial extension of inverted papilloma is mostly associated with recurrent disease. Intracranial extradural inverted papilloma can be effectively controlled with craniofacial resection. Intracranial intradural involvement of inverted papilloma has a poor prognosis regardless of treatment. Aggressive treatment of intranasal inverted papilloma may be the most important factor in preventing intracranial presentation.
本文旨在明确内翻性乳头状瘤颅内侵犯的结果,并概述针对这种罕见临床表现的治疗基本原理。
对文献报道的(18例患者)或在我们机构接受治疗的(3例患者)内翻性乳头状瘤颅内侵犯患者进行回顾。对这21例患者的临床表现、治疗及结果等数据进行汇总。9例患者(包括我们的1例病例)合并有鳞状细胞癌,因此被排除在分析之外。12例“单纯”内翻性乳头状瘤患者构成了本研究的基础。
大多数颅内内翻性乳头状瘤患者(83%)存在复发性疾病。硬膜外病变患者的生存率为86%,平均随访4.4年。这些幸存者中有86%接受了颅面切除术治疗。相比之下,硬膜内内翻性乳头状瘤患者中有75%死于疾病,平均随访9.3个月,无论采用何种治疗方式。
内翻性乳头状瘤颅内侵犯大多与复发性疾病相关。颅内硬膜外内翻性乳头状瘤可通过颅面切除术有效控制。内翻性乳头状瘤颅内硬膜内侵犯无论采用何种治疗,预后均较差。积极治疗鼻内翻性乳头状瘤可能是预防颅内表现的最重要因素。